Roivant Sciences (ROIV) Enterprise Value Growth (1y) (2022 - 2026)
Roivant Sciences (ROIV) Enterprise Value Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.83% |
| Dec 31, 2025 | -8,873.63% |
| Sep 30, 2025 | -108.47% |
| Jun 30, 2025 | 26.71% |
| Mar 31, 2025 | 58.13% |
| Dec 31, 2024 | 99.34% |
| Sep 30, 2024 | -48.53% |
| Jun 30, 2024 | -321.06% |
| Mar 31, 2024 | -388.23% |
| Dec 31, 2023 | -258.08% |
| Sep 30, 2023 | -1.83% |
| Jun 30, 2023 | 17.01% |
| Mar 31, 2023 | 47.88% |
| Dec 31, 2022 | 17.45% |
| Sep 30, 2022 | 57.05% |
| Jun 30, 2022 | 26.91% |
| Mar 31, 2022 | -6.40% |